NCT00121316View on ClinicalTrials.gov

Safety and Efficacy of Pimecrolimus Cream 1% in Mild to Moderate Head and Neck Atopic Dermatitis (AD) Patients

PHASE4CompletedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

October 31, 2004

Study Completion Date

July 31, 2005

Conditions
Atopic Dermatitis
Interventions
DRUG

Pimecrolimus

Pimecrolimus Cream 1 %

DRUG

Placebo

Vehicle cream (placebo cream)

Trial Locations (1)

Unknown

This study is not being conducted in the United States, Novartis Pharma AG

Sponsors

Lead Sponsor

Novartis
All Listed Sponsors
lead

Novartis

INDUSTRY